pyrroles has been researched along with insulin glargine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amiel, SA; Aylwin, SJ; Huda, MS; Ross, P | 1 |
1 other study(ies) available for pyrroles and insulin glargine
Article | Year |
---|---|
Tyrosine kinase inhibitor sunitinib allows insulin independence in long-standing type 1 diabetes.
Topics: Antineoplastic Agents; Diabetes Mellitus, Type 1; Fatal Outcome; Female; Humans; Hypoglycemia; Hypoglycemic Agents; Indoles; Insulin Aspart; Insulin Glargine; Insulin, Long-Acting; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Protein Kinase Inhibitors; Pyrroles; Sunitinib | 2014 |